Jack E. Stover - 19 Jun 2025 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Reporting relationship
Director
Issuer ticker
TRAW
Reported as of
19 Jun 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Jun 2025, 17:54:01 UTC
Prior SEC filing
14 Aug 2023
Next SEC filing
15 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jack E. Stover

Key filing fact

Jack E. Stover filed Form 4 for Traws Pharma, Inc. (TRAW) on 23 Jun 2025.

Key facts

  • This page summarizes Jack E. Stover's Form 4 filing for Traws Pharma, Inc. (TRAW).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 23 Jun 2025, 17:54.

Change

  • Previous filing in this sequence was filed on 14 Aug 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001203603 Primary reporting owner

STOVER JACK E

Relationship
Director
Address
C/O TRAWS PHARMA, INC, 12 PENNS TRAIL, NEWTOWN
Signature
/s/ Jack E. Stover
Signature date
23 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRAW transaction Derivative

Stock Option (right to purchase)

Award

Transaction value
$0
Shares
+23,000
Change %
Price
$0.000000
Shares after
23,000
Date
19 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,000
Exercise price
$1.65
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options vest 100% on the first anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .